Breaking this hour… Eli Lilly’s oral weight-loss pill approved by the FDA. What the company’s CEO told CNBC about the growth story. Then new reports say SpaceX has confidentially filed for an IPO. Plus, which companies could be the next target of an activist investor? Barclays with a new report looking at just that.<br><br>Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Eli Lilly’s Oral GLP-1 Approved, SpaceX Confidentially Files for IPO, Potential Activist Targets 4/1/26

CNBC’s “Money Movers”

Good Wednesday morning. Welcome to Money Movers. I'm Carl Quintanilla with Sarah Eisen, live at Post 9 to the New York Stock Exchange. Stocks continue to rally here on this Iran war optimism. The president says Iran has asked for a ceasefire. We're joined by one former top U.S. Mid-East diplomat who says none of the options on the table right now are very good. Plus, activist investors putting M&A back in the spotlight with Q1 notching a record number of mega deals. We'll discuss which sectors remain ripe for shareholder activism and deals for the remainder of 2026.

Crypto investment firm CoinShares making its Nasdaq debut. We're joined by the CEO to talk about their growth strategy. Crypto stocks have seen a sector-wide decline over the past six months. First up, though, in the markets, as Carl mentioned, there is optimism. And you see that in this rally, which is extended from yesterday, which was another broad rally. S&P 500 up another 1%. It's pretty broad. The only sectors lower right now are energy and consumer staples, which, of course, were the outperformers during the war.

And the concerns there about higher oil prices and the economy. Industrials, so cyclical groups at the top of the market, up 2% today. Communication services, information technology. As we try to monitor whether this comeback can continue after a rough start to the year, treasuries are also rallying, turned around a little bit, with the 10-year yield down to 4.3% on the back of some better, I would say, economic data.

Yes. Let's begin with the latest in Iran today. The president, of course, is set to address the nation tonight. Our Eamon Javers is in D.C. Morning, Eamon. Yeah, good morning to you, Carl.

Eli Lilly’s Oral GLP-1 Approved, SpaceX Confidentially Files for IPO, Potential Activist Targets 4/1/26

Read the full transcript

The candid version is on a podcast,
not the earnings call.

Eli Lilly’s Oral GLP-1 Approved, SpaceX Confidentially Files for IPO, Potential Activist Targets 4/1/26

Read the full transcript

The candid version is on a podcast, not the earnings call.

The candid version is on a podcast,
not the earnings call.